BioSpace News Archive

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced two data presentations, highlighted data from the UNITY-CLL Phase 3 trial evaluating the combination of ublituximab and UKONIQ (umbralisib), the Company’s inhibitor of PI3K-delta and CK1-epsilon, (U2).

atai Life Sciences today announced positive topline data from its Phase 2a study of RL-007 for Cognitive Impairment Associated with Schizophrenia (CIAS).

Mind Cure Health Inc. announces the appointment of Doron Sagman , MD, FRCPC, as the Company’s new Chief Medical Officer.

Astellas Venture Management LLC (President: Kazunori Maruyama, Ph.D, “AVM”), a wholly-owned venture capital subsidiary of Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”), and Mission Bay Capital BioLabs (“MBC BioLabs”), a life-science incubator, today announced Vcreate and Weatherwax Biotechnologies as the winners of the Astellas-sponsored “Future Innovator Prize” at MBC BioLabs.